Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. (Q51385774)
Jump to navigation
Jump to search
scientific article published in January 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study. |
scientific article published in January 2011 |
Statements
Safety and efficacy of linagliptin as add-on therapy to metformin in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled study (English)
J Rosenstock
I Tamminen
R Kubiak
S Patel
K A Dugi
1 January 2011